Literature DB >> 8387640

Therapy for human immunodeficiency virus infection.

M S Hirsch1, R T D'Aquila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8387640     DOI： 10.1056/NEJM199306103282307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  Combination therapy as a tool to prevent emergence of bacterial resistance.

Authors:  J W Mouton
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Metabolic characterization of a tripeptide human immunodeficiency virus type 1 protease inhibitor, KNI-272, in rat liver microsomes.

Authors:  A Kiriyama; T Nishiura; H Yamaji; K Takada
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

3.  Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.

Authors:  H H Kupferschmidt; K E Fattinger; H R Ha; F Follath; S Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

4.  The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts.

Authors:  S Crystal; U Sambamoorthi; C Merzel
Journal:  Health Serv Res       Date:  1995-10       Impact factor: 3.402

5.  ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Authors:  D J Kempf; K C Marsh; J F Denissen; E McDonald; S Vasavanonda; C A Flentge; B E Green; L Fino; C H Park; X P Kong
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 6.  Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).

Authors:  P Portegies
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

Authors:  F Shaheen; L Duan; M Zhu; O Bagasra; R J Pomerantz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 8.  Care of HIV-positive obstetric patients. Meeting a multigenerational challenge.

Authors:  C M Peckan
Journal:  Can Fam Physician       Date:  1994-08       Impact factor: 3.275

9.  ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease.

Authors:  H L Sham; D J Kempf; A Molla; K C Marsh; G N Kumar; C M Chen; W Kati; K Stewart; R Lal; A Hsu; D Betebenner; M Korneyeva; S Vasavanonda; E McDonald; A Saldivar; N Wideburg; X Chen; P Niu; C Park; V Jayanti; B Grabowski; G R Granneman; E Sun; A J Japour; J M Leonard; J J Plattner; D W Norbeck
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.

Authors:  S D Malley; J M Grange; F Hamedi-Sangsari; J R Vila
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.